HEPATITIS B, CHRONIC

This large, late-stage study is testing whether a new drug called bepirovirsen can provide a functional cure for chronic Hepatitis B. It involves 857 people who are already taking standard antiviral medication. The goal is to see if adding bepirovirsen for 24 weeks can suppress t…

This large Phase 3 study is testing whether an investigational drug called bepirovirsen can provide a 'functional cure' for people with chronic Hepatitis B. It involves nearly 1,000 participants who are already on standard antiviral medication. The main goal is to see if adding b…

This study is testing combinations of three investigational drugs (VIR-2218, VIR-3434, and/or PEG-IFNα) in people with chronic hepatitis B infection. The main goals are to see if these treatments are safe and if they can help the body clear the hepatitis B virus or significantly …

This study is testing whether some adults with chronic hepatitis B can safely stop their long-term antiviral medication. Researchers will follow 140 patients who stop treatment and compare them to 700 similar patients who continue medication. The goal is to see if stopping is saf…

This study is testing an investigational drug called AHB-137 in people with a specific type of chronic hepatitis B who are already taking standard antiviral pills. The main goal is to see if adding AHB-137 can further reduce the amount of virus in the blood and potentially allow …

This early-stage study is testing a new injectable drug called AHB-137 for people with chronic Hepatitis B. It first checks if the drug is safe in healthy volunteers, then gives it to Hepatitis B patients who are already on stable antiviral pills. The main goal is to see if addin…